Navigation Links
New lung cancer research presented at CHEST 2008
Date:10/27/2008

#7725
YOUNGER PATIENTS WITH LUNG CANCER HAVE BETTER SURVIVAL

(Tuesday, October 28, 1:00 PM EST)

Lung cancer in younger patients may exhibit distinct clinical features than lung cancer in older patients, including better survival rates at each disease stage. Researchers from Stanford Cancer Center in California compared disease characteristics and survival of lung cancer patients aged 15 to 39 years at diagnosis with patients aged ≥40 years at diagnosis. The age-adjusted incidence rate of lung cancer in patients aged 15 to 39 years was 1.2 per 100,000, whereas the rate in patients aged ≥40 years was 141 per 100,000. A higher proportion of younger patients (57 percent) had distant disease at diagnosis compared with older patients (51 percent). Mean 5-year cause-specific survival was 34 percent in the group of patients aged 15 to 39 years and 16 percent in the group aged ≥40 years. In addition, at each disease stage, mean 1- and 5-year cause-specific survival rates were better in the younger group.

#7701
HERBAL REMEDIES MAY HELP PATIENTS WITH ADVANCED LUNG CANCER

(Wednesday, October 29, 1:00 PM EST)

The use of herbal remedies may be an effective supportive therapy to control symptoms and improve quality of life in patients with advanced stage lung cancer. Researchers from Jafary Medical Clinics in West Virginia followed 15 patients with end-stage primary lung cancer who failed to improve with a conventional treatment of chemotherapy and radiation therapy. Patients were treated with American ginseng for fatigue, morphine sulfate for control of severe dyspnea and pain, licorice root powder for control of severe coughing spells, and bilevel pressure ventilation for respiratory depression related to IV morphine. Two patients also were taking oldenlandia, a Chinese herb for lung cancer. Results showed that licorice and ginseng were effective therapies for the majority of patients, and mor
'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Doctors Test Advanced Tool for Treating Prostate Cancer
2. Hooters to Hooters 80 Mile Bicycle Ride Supporting Local American Cancer Society Unit
3. Statins Lower Risk of Clots in Cancer Patients
4. Most Off-Label Cancer Drug Use for Palliative Care
5. Get Screened Video Contest Throws a Spotlight on the Importance of Colorectal-Cancer Screening
6. MicroRNAs make for safer cancer treatments
7. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
8. Aflac Cancer Center and Blood Disorders Service Unveils New Carl Edwards Triage Room
9. USC Cancer Center Announces Contribution By Larry and Judy Freeman
10. Study finds that practice makes perfect in lung cancer surgery
11. Researchers Find More Genes Linked to Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 issue of The FASEB Journal ... a simple blood test. This test, called the "lymphocyte genome ... than ever before, but it may eliminate the need for ... likely to develop cancer in the future. , "The ... peoples, lives," said Diana Anderson, a researcher involved in the ...
(Date:9/30/2014)... HealthDay Reporter MONDAY, Sept. 29, 2014 ... -- artificial valves, hip replacements, surgical mesh and the like ... after their approval by the U.S. Food and Drug Administration, ... prominent nonprofit groups and published online Sept. 29 in ... medical device testing on lax oversight by the FDA. ...
(Date:9/30/2014)... 30, 2014 Edward D. Buckingham, M.D., ... has been approved to be a director of a ... Reconstructive Surgery (AAFPRS) fellowship program. The announcement came last ... Florida. , The Educational and Research Foundation for the ... It represents the finest postgraduate program in the world ...
(Date:9/30/2014)... NC (PRWEB) September 30, 2014 ... and caring individuals, National Children’s Oral Health ... $150,000 in grants to non-profit clinical partners. ... Affiliate Network and deliver comprehensive educational, preventive ... , Recipients include:,     Just ...
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- Herceptin is ... cancer called HER2-positive and should remain the standard of ... findings from a long-term clinical trial. HER2-positive breast ... of breast cancer, according to the Mayo Clinic. ... countries received either Herceptin (trastuzumab) or Tykerb (lapatinib) in ...
Breaking Medicine News(10 mins):Health News:New blood test determines whether you have or are likely to get cancer 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 3
... Dr. Jacob Bolotin Awards Presented at 2008 Convention, ... of,the Blind presented $100,000 in cash awards to ... achieving the,full integration of the blind into society ... Bolotin Awards honored ten innovators in the blindness,field ...
... 7 The Peer Group, a leading provider,of ... an,Informed Medical Communications (IMC) company, today announced the ... innovation in moderated,peer influence events whereby two Key ... data, product attributes, and prescribing,experience in a debate-style ...
... of potent, or ,high affinity, antibodies to fight infection. The ... it hinges on a single molecule, a growth factor, without ... do not yet understand about our immune system. In simple ... T cells, which help them. Ways in which these cells ...
... BETHLEHEM, Pa., July 7 MIKE AND IKE(R) Lemonade,Blends(TM) ... candy fans who are members of the facebook(R) community ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/justborn/33812/ ... Foundation will encourage,their fans who are active on facebook(R) ...
... Corporation (Pink,Sheets: BDRR), a medical imaging and diagnostic ... Network (OTCFN), a division of National,Financial Communications Corp., ... president of OTCFN, said, "In 2007, Bederra generated,revenues ... $471,182, or,approximately $0.01 per share, and has some ...
... Engage Contract Sales Organization And Seek New Marketing ... Partner to Promote Product in UK -, ... DDSS) today announced that it has reacquired the sales and,marketing rights ... Recordati Ireland Ltd. (Recordati). To promote its,product in the UK, the ...
Cached Medicine News:Health News:National Federation of the Blind Awards $100,000 2Health News:The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs 2Health News:Finding suggests novel ways to boost vaccination or natural defenses 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 3Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 2Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 3Health News:Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product 2
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern ... Both established medical-device providers as well as new medical-device ... region, while simultaneously looking at ways to reduce the ... Using distributors is one of the effective means to ... devices distribution market in Eastern European and provides profiles ...
(Date:9/30/2014)... New York , September 30, 2014 ... - Global Industry Analysis, Market Size, Share, Growth and ... is expected to be worth USD 20.8 billion in ... billion in 2017, growing at a CAGR of 7.3% ... fundamental elements needed for various health purposes, especially to ...
(Date:9/30/2014)... 30, 2014 In a recent ... Fluid) backflow of the Eldor spinal needle 25G, 103 ... hole pencil point spinal needles of the same gauge ... Spinal anesthesia is an excellent type of regional anesthesia ... Anesthesia, etc. It is estimated that 100 ...
Breaking Medicine Technology:Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
... Mich., Nov. 9 Thomson Reuters today ... leading clinical surveillance solution that enables hospitals to identify ... clinical quality and reduce total cost of treatment. , ... no additional cost. , CareFocus 2.0 contains ...
... Shire plc (LSE: SHP, Nasdaq: ... availability of INTUNIV (TM) (guanfacine) Extended Release ... of Attention-Deficit/Hyperactivity Disorder ( ADHD ) in children ... formulation of guanfacine, is the first and only nonscheduled alpha-2A ...
Cached Medicine Technology:Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7
Remote Controlled, Easy to Use,Vision Tester Designed for Screening Children Ages 3 and Older.,Excellent for Pediatric and School Markets....
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: